Why SNOMED CT? New platform presents a refreshed case for investing in the comprehensive clinical terminology

SNOMED International released today its refreshed SNOMED CT Case for Investment report.

London, United Kingdom, Dec. 16, 2021 (GLOBE NEWSWIRE) — SNOMED International released today its refreshed SNOMED CT Case for Investment report. Available on a new interactive platform, the Case for Investment presents evidence that SNOMED CT adds measurable value to a broad range of primary and secondary health processes leveraging SNOMED CT encoded data to enable improved patient outcomes. Through the narrative, the report provides accessible and understandable answers to questions such as, “what is SNOMED CT?”, ‘what makes SNOMED CT unique?’, “how and where is it in use globally?” and “why invest in SNOMED CT?”

SNOMED CT, the most comprehensive and multilingual clinical healthcare terminology in the world, possesses unique characteristics that differentiate it from other classifications and terminologies. Among these characteristics are SNOMED CT’s position as a core reference terminology, its clinically comprehensive 350,000+ concepts supported by a machine-readable semantic network, broad use and mandate in select countries.

Showcasing real world use and outcomes of SNOMED CT is the best way to demonstrate its value, understanding that SNOMED CT must be embedded in a clinical information system, health data & analytics platform or an interoperability solution for it to function. Through the Case for Investment, 10 examples of SNOMED CT use across data entry and integration, clinical information sharing, point of care analytics, population and management analytics and research domains have been featured. Ranging across different countries such as Australia, Canada, China, United Kingdom, United States, continued collection of additional SNOMED CT case studies remains an ongoing priority.

SNOMED International CEO, Don Sweete, commented on the development and outcomes of the Case for Investment. “There has been a tremendous evolution in SNOMED CT over the past 10 years and this report demonstrates the value that it offers healthcare systems and stakeholders worldwide” said Sweete. “With a complement of 41 Members that represent health systems globally, continuously refreshed knowledge and analysis on the nature, utility and value of standards like SNOMED CT can’t be overstated. Health system decision-makers need to be equipped with clear knowledge of how their investments in SNOMED CT translate into positive outcomes for the health of their nation’s citizens.”

In terms of conclusions, the report presents SNOMED CT as a scalable and “fit for purpose” clinical terminology, adhering to international criteria, data quality and suitability requirements. A part of the bigger picture, SNOMED CT is one of many contributing factors to improving patient outcomes, and studies show that the use of SNOMED CT-embedded systems can provide significant qualitative and quantitative patient outcome benefits.

Looking forward, SNOMED CT must also contemplate how it enables the future needs of medicine and research. A healthcare industry that is ever evolving, the future opportunities for SNOMED CT will be driven by new healthcare data sources and new healthcare technologies such as national cohorts, big data and AI, clinical genomics, phenomics and environment, etc.

Experience the breadth of the SNOMED CT Case for Investment through the organization’s interactive value platform at value.snomed.org.

Attachment

Kelly Kuru
SNOMED International
comms@snomed.org

Nikkiso Clean Energy & Industrial Gases Group devient membre ambassadeur de California Fuel Cell Partnership

TEMECULA, Californie, 15 déc. 2021 (GLOBE NEWSWIRE) — Nikkiso Clean Energy & Industrial Gases Group (Groupe), une filiale de Nikkiso Co., Ltd (Japon), est fier d’annoncer qu’il a rejoint le California Fuel Cell Partnership (CaFCP) en tant qu’ambassadeur.

Cette association travaille à établir 200 stations de ravitaillement en hydrogène d’ici 2025 en vue d’un avenir durable pour les voitures, les camions et les bus à zéro émission. Rejoindre le CaFCP s’inscrit dans l’engagement du Groupe à mener le changement vers un monde plus sain. En outre, le Groupe étend ses activités mondiales et ouvre une nouvelle installation d’ingénierie et de service à Houston et en Corée cette année, ainsi qu’un nouveau centre en Allemagne en 2022.

« Nous sommes ravis de faire partie du CaFCP pour fournir des alternatives énergétiques propres et nous sommes impatients de collaborer avec d’autres membres du CaFCP sur le marché du carburant hydrogène pour les piles à combustible », a déclaré Peter Wagner, PDG de Nikkiso Clean Energy & Industrial Gases Group.

Plusieurs nouveaux produits à base d’hydrogène sont en cours de développement, tels que les premières pompes mobiles à ravitaillement en hydrogène, les pompes à hydrogène alternatives haute capacité/haute pression et les stations de ravitaillement en hydrogène liquide conteneurisé. Ceci s’ajoute à leur capacité à fournir des projets d’ingénierie, des projets d’approvisionnement et des projets complets clés en main.

À PROPOS DE CRYOGENIC INDUSTRIES
Cryogenic Industries, Inc. (aujourd’hui membre de Nikkiso Co., Ltd) et ses entreprises membres fabriquent des équipements et de petites usines de traitement du gaz cryogénique pour les secteurs du gaz naturel liquéfié (GNL), des services d’entretien de puits et du gaz industriel. Fondée il y a plus de 50 ans, Cryogenic Industries est la société-mère d’ACD, de Cosmodyne et de Cryoquip, ainsi qu’un groupe administré en commun comptant une vingtaine d’entités opérationnelles.

Pour tout complément d’information, veuillez consulter les sites www.nikkisoCEIG.com et www.nikkiso.com.

Contact auprès des médias :
Anna Quigley
+1.951.383.3314
aquigley@cryoind.com

Clean Energy & Industrial Gases Group da Nikkiso torna-se membro embaixador da California Fuel Cell Partnership

TEMECULA, Califórnia, Dec. 15, 2021 (GLOBE NEWSWIRE) — O Nikkiso Clean Energy & Industrial Gases Group (Grupo), subsidiária da Nikkiso Co., Ltd (Japão), tem o orgulho de anunciar a sua entrada para a California Fuel Cell Partnership (CaFCP) como embaixador.

A associação está no processo de estabelecer 200 estações de abastecimento de hidrogênio até 2025 para um futuro sustentável para carros, caminhões e ônibus de emissão zero. A adesão à CaFCP faz parte do compromisso do Grupo de liderar a mudança para um mundo mais saudável. Além disso, o Grupo está expandindo suas operações em todo o mundo, com a inauguração novas instalações de engenharia e serviço em Houston e na Coréia este ano e um novo centro na Alemanha em 2022.

“Estamos contentes em fazer parte da CaFCP para fornecimento de alternativas de energia limpa e estamos prontos para colaborar com outros membros da CaFCP no mercado de hidrogênio de células de combustível”, disse Peter Wagner, CEO do Nikkiso Clean Energy & Industrial Gases Group.

Existem vários novos produtos de hidrogênio em desenvolvimento, como as primeiras bombas móveis de reabastecimento de hidrogênio, bombas de hidrogênio alternativo de alta capacidade/alta pressão e estações de reabastecimento de hidrogênio líquido em contêiner. Além da capacidade de fornecer projetos de engenharia, compras e turnkey completos.

SOBRE A CRYOGENIC INDUSTRIES
A Cryogenic Industries, Inc. (agora membro da Nikkiso Co., Ltd.) fabrica equipamentos de processamento de gás criogênico projetados e plantas de processo de pequena escala para as indústrias de gás natural liquefeito (GNL), serviços de poços e gás industrial. Fundada há mais de 50 anos, a Cryogenic Industries é a empresa controladora da ACD, Cosmodyne e Cryoquip, e de um grupo comumente controlado de aproximadamente 20 entidades operacionais.

Para mais informação, visite www.nikkisoCEIG.com e www.nikkiso.com.

CONTATO COM A MÍDIA:
Anna Quigley
+1.951.383.3314
aquigley@cryoind.com

Casio lance des modèles G-SHOCK en collaboration avec la série documentaire télévisée Matchday : Inside FC Barcelona

TOKYO, 15 décembre 2021 /PRNewswire/ — Casio Computer Co., Ltd. a annoncé aujourd’hui les dernières nouveautés de sa marque de montres antichocs G-SHOCK. Le GBD-H1000BAR et le GBD-100BAR sont des modèles de collaboration célébrant Matchday: Inside FC Barcelona, un documentaire sur le monde intérieur du célèbre club de football espagnol.

GBD-H1000BAR (left), GBD-100BAR (right)

Les modèles de base des deux nouvelles montres sont le GBD-H1000 et le GBD-100, tous deux issus de la gamme G-SQUAD. Les nouveaux modèles reprennent les couleurs bleu et grenat de l’équipe du FC Barcelone. Les bracelets, conçus pour évoquer les uniformes passés et présents de l’équipe, sont imprimées de la devise du club, « Més que un club » (« Plus qu’un club ») dans la langue catalane locale. Le GBD-H1000BAR est dotée d’une lunette en métal plaqué or ionique brillant comme une coupe de trophée de vainqueur, tandis que la boucle du bracelet des deux montres arbore les quatre bandes rouges du drapeau catalan. Un emballage spécialement conçu, également aux couleurs de l’équipe du FC Barcelone, est une touche finale digne de ces montres singulières.

GBD-H1000BAR / GBD-100BAR

Les deux nouvelles montres sont équipées d’un accéléromètre pour compter les pas et suivre les distances. Le GBD-H1000BAR est également équipé d’un moniteur de fréquence cardiaque et d’un suivi GPS. Les deux nouveaux modèles offrent également des fonctions de liaison mobile qui, lorsqu’elles sont associées à une application smartphone dédiée, favorisent la gestion quotidienne de la santé en permettant aux utilisateurs de consulter les journaux de vie avec des données sur le nombre de pas et les calories brûlées, les journaux d’activité, etc. L’écran LCD à mémoire en pixels (MIP) pour une visibilité exceptionnelle et le bracelet en uréthane souple, pour une ventilation et une flexibilité exceptionnelles, offrent un confort dans toutes les situations, de l’utilisation quotidienne aux entraînements intensifs.

Special packaging (GBD-H1000BAR [left]; GBD-100BAR [right])

Matchday: Inside FC Barcelona

Une série documentaire en huit épisodes centrée sur la saison 2018-2019 de l’un des clubs de football les plus adulés au monde. Du frisson de la victoire à l’agonie de la défaite, la série offre un aperçu des joueurs, de la philosophie et de la culture du FC Barcelone.

Photo : https://mma.prnewswire.com/media/1708036/image_1.jpg

Photo : https://mma.prnewswire.com/media/1708149/image_2.jpg

Photo : https://mma.prnewswire.com/media/1708038/image_3.jpg

FDA destroys unwholesome products in Takoradi

Sofokrom (W/R),- The Food and Drugs Authority (FDA) has destroyed quantities of unwholesome drugs and other sub-standard products on markets in Takoradi.

These include herbal mixtures, bloated canned foods, various sexual enhancement drugs, groceries and ointments and were seized from importers at the ports and from peddlers and shops in the Western Region.

They were either expired, illegally imported, fake or unregistered and were burnt to ashes at the Sofokrom Final Waste Disposal Site to prevent them from finding their way back to the markets.

Briefing the Ghana News Agency in Takoradi, Mr Prince Ebo, a Regulatory Officer of the FDA, said the safe disposal of the items followed recent post-market surveillance the Authority conducted.

The items were seized from traders in the Western and Western North regions between September and December 2021.

He expressed concern over the growing interest of women peddling pharmaceuticals of dubious origin on the streets and pledged the FDA’s resolve to holistically deal with the trend.

He cautioned the public against the sale and purchase of expired, fake, and unregistered products on the markets and advised them not to be concerned only about the expiry dates but also check the general state of the products.

Mr Ebo urged the public to report to the Authority if they had doubts about the wholesomeness of any product on the market for the necessary action to be taken.

Products with user instructions in languages other than English should be avoided since consumers may not know how such products worked or what they contained, he said.

Source: Ghana News Agency

Our chances of winning the Ghana Premier League title is still intact – Prosper Narteh Ogum

Prosper Narteh Ogum has reiterated that Asante Kotoko’s chances of winning the 2021/22 Ghana Premier League title is still intact despite their recent struggle.

The Porcupine Warriors were held at home in the matchday 8 games on Wednesday by RTU in a 1-1 drawn game.

The draw mean Kotoko have gone three matches without a win.

In his post-match interview with StarTimes, Prosper Narteh said they failed to utilize the goal-scoring opportunities that came their way and that has been the problem they are facing right now.

Also, he added by saying their chances of winning the league is still on track since there are still lots of games to spare.

“I wasn’t frustrated. We played well, created chances but just that we failed to convert them. We are winless in our last three games because we don’t take our chances and that is the problem now,” he said.

“We didn’t really miss any of the injured players’ because we played well, if they were there it would have been good but we didn’t miss them.

“Of course, our chances to win the league is still bright cos we have played only 8 games out of 34 so we have still got more to play,” he added.

Asante Kotoko currently sit 3rd with 14 points.

Source: Modern Ghana

Medical Credit Fund raises EUR 32.5 million to support health entrepreneurs in sub-Saharan Africa

Medical Credit Fund (MCF), the only debt fund fully dedicated to the African health sector, today announced the completion of a EUR 32.5 million fundraise of its second fund (MCF II).

This financing round will expand the Fund’s presence and support to healthcare providers in sub-Saharan Africa, with a focus on primary healthcare services including malaria prevention and treatment and maternal and childcare. This round of financing also caters for expanding its fully digital loan product called ‘Cash Advance’, which grew exponentially in the past two years.

The funding round was anchored by the Dutch Ministry of Foreign Affairs, which provided the first equity injection of EUR 7.5 million in January this year, to cater to the demand for loans during the heights of the COVID-19 crisis.

Also participating in this funding round are CDC Group, EUR 10 million, FMO, EUR 7.5 million, SwedFund, EUR 5 million and Philips, EUR 2.5 million. In addition, MCF will benefit from a guarantee facility by the U.S. International Development Finance Corporation (DFC), which was initiated by the Health Finance Coalition (HFC) with support of the U.S. President’s Malaria Initiative (PMI) and USAID’s Center for Innovation & Impact (CII).

Through blended finance, MCF uses catalytic capital from both public and private sources and is targeting to grow to EUR 80 million in the next few years.

MCF II qualifies under the 2X Challenge as its funding will enhance access to capital for gender-smart healthcare businesses and help to increase health services for female patients. The 2X Challenge is a commitment by the development finance institutions (DFIs) of the G7 to mobilize capital to support businesses, provide women in emerging economies with access to leadership opportunities, quality employment, and products and services that enhance their economic participation and inclusion.

Medical Credit Fund will deploy the funding to advance its product offering and digital loans across sub–Saharan Africa. Mitigating the chronic underfunding of the sector means more patients can receive better healthcare and stimulate efficiencies; facilitating and stimulating loans, business support, and investments for private health care providers, and innovating value-based health care solutions and financing, using data to empower health care consumers, patients, doctors and financiers alike.

Since its establishment, Medical Credit Fund has provided over 6,500 loans to healthcare providers in Africa, worth over EUR 120 million, with a 96% repayment rate. It has reached 1,800 health small and medium-sized enterprises (SMEs) in Kenya, Ghana, Nigeria, Tanzania and Uganda. Loans are combined with support for business and quality improvement using the PharmAccess – SafeCare standards and methodology, through which more than 80% of the clients are able to improve their services.

MCF will deploy the funding to further scale its impact across sub-Saharan Africa with a focus on advancing its digital loan products. Only 5 years after introducing ‘Cash Advance’, 80% of MCF’s disbursements now go through digital loans. Cash Advance does not require collateral: the provider’s history of mobile money receipts serves as the basis for the loan. The digital revenues are used directly to pay back the loan.

The Country Director of MCF, Mr. Derrick Ewudzie-Odoom said, “For us in the Medical Credit Fund, the raising of this new fund means that the work we have been doing in improving quality healthcare financing is significantly changing and transforming the healthcare financing landscape in Ghana and the sub region and making MCF an attractive partner for impact financing..”

“This requires that we do more to improve and impact more lives through the financing of medical quality improvement and strengthen the businesses of our partner healthcare providers.”

Mr. Derrick Ewudzie-Odoom, noted that the MCF is poised to mobilize more risk capital and make them available to private (including faith-based) and quasi-public health providers in sub-Saharan Africa; all in the bid to increase access to quality healthcare delivery towards achievement of Universal Health Coverage.

Medical Credit Fund and the COVID-19 pandemic in Ghana

Mr. Derrick Ewudzie-Odoom, said The Medical Credit Fund (MCF) is well-positioned to assist hospitals in Ghana to combat the spread of the novel Coronavirus disease (COVID-19) which has become a global pandemic.

According to the Country Director of MCF, “The Fund is in prime position to offer access to finance and quality improvement programmes to help deal with the healthcare needs of Ghanaian citizens.”

Mr. Ewudzie-Odoom said, the MCF is capable of extending loan facility ranging between €5,000 and €2.5 million equivalent in Ghana Cedis to private and quasi-public health facilities including pharmaceutical companies to expand their infrastructure, purchase medical supplies (medicines and consumables) and equipment for the management of diseases including COVID-19.

Medical Credit Fund impact on Ghana
Mr. Ewudzie-Odoom said the Medical Credit Fund does not only provide financing to hospitals and clinics but to other players in the health industry such as pharmaceutical manufacturers and wholesalers, pharmacies, laboratories, diagnostic centres, medical suppliers, and health training institutions.

Established in 2009 as part of the PharmAccess Group, the Medical Credit Fund is the only fund dedicated to financing small and medium-sized healthcare facilities in Africa.

In Ghana, MCF has disbursed over 860 loans worth $25 million to heath SMEs across the length and breadth of the country. Since the beginning of 2021, MCF has for instance provided financing to some of the top pharmacy retail chains to expand their operations in Accra, Takoradi, Mankessim, Cape Coast, Kumasi, Bolgatanga and Koforidua in a bid to make available drugs for the treatment of malaria and other prevalent diseases. MCF has also supported a fully Ghanaian-owned company that is about to manufacture medical gloves and condoms among other latex products in the western region of Ghana. An Accra-based private hospital that has expanded its operations to the Western Region, specifically in Elubo has also obtained financing from MCF.

In Wenchi in the Bono East Region, MCF is financing the construction of a whole new 100-bed hospital facility which will not only serve the people of Wenchi but also its surrounding towns and villages. In the area of medical equipment, MCF has financed some local equipment vendors and also collaborated with major international equipment suppliers to retool hospitals.

The public health system across Africa especially the private healthcare sector faces many challenges which include capacity and quality of care. For small and medium enterprises (SMEs), it is even more challenging to access loans to invest and expand their healthcare facilities and services.

By reducing the perceived risks of investing in this sector, MCF provides liquidity to Health SMEs that find it difficult to secure formal bank loans. The funds are then invested in facilities, equipment, infrastructure, commodities, staff and systems that deliver enhanced care to all patients supported by the internationally accredited SafeCare program.

He said the Medical Credit Fund in partnership with the NHIA and other institutions such as CHAG have a certain arrangement that allows the MCF to pre-finance the vetted claims of medical facilities. “This allows the facilities to run effectively while they wait for NHIA to reimburse such claims,” he added.

According to Mr. Ewudzie-Odoom, this NHIA claims pre-financing has saved many hospitals and clinics by providing them with regular access to financing.

Source: Ghana Web

Jupitar lines up top stars for “The One” concert

Accra,- Ghanaian Dancehall/Reggae artiste Jupitar, says “The One” Concert fixed for Saturday, December 18, offers him the opportunity to connect with his fanbase as they celebrate Ghanaian Dancehall music.

The Fantasy Dome would be the centre of attraction when the highly anticipated “The One Concert” takes place with a star-studded artiste line up.

Artistes billed to perform at the concert include multiple award-winning Reggae and Dancehall star Samini, Larruso, Kelvyn Boy, Kofi Jamar, D-Black, Sefa, Yaa Pono, among others.

Speaking in an interview with GNA Entertainment ahead of the concert, Jupitar revealed how ecstatic he was about getting the chance to reconnect with his fans and cannot wait for it to get underway.

“There would be more surprises on the night and Reggae/Dancehall fans should expect a fiesta of good music. I have not held any concerts in Ghana over the past two years due to the global pandemic.

“I have not had the chance to connect with my fans and this concert offers me the platform to reconnect with my fans. So, it’s all about cheering them up ahead of the upcoming festive season and they should come in their numbers,” he said.

The concert is part of activities to climax the release of the multi-genre “The One” which debuted in March and has performed well on music charts around the world.

Source: Ghana News Agency